Similarly, no increased signal of arrhythmia, heart failure, or major cardiovascular events has emerged in the data published to date
If you experience severe vomiting or diarrhea, temporarily hold your next dose and contact your healthcare provider, as dehydration can increase the risk of acute kidney injury
You can find more about preventing these issues in peptide-storage-stability-guidelines-2
Compound Specifications Research Peptide Blend Laboratory Research Use Only Product Details Sizes: 5mg + 5mg, 10mg + 10mg Compounds: BPC-157 and TB-500 BPC-157 CAS: 137525-51-0 TB-500 CAS: 885340-08-9 Form: Lyophilized powder blend Quality: High-purity, batch documented Testing: View COA documentation Testing: View COA (Verified by Janoshik) BPC/TB blend documentation path This listing separates compound identity, vial composition, and batch documentation so researchers can review the material without protocol-style claims
The drug was never specifically approved by the FDA for weight loss, though
In fact, FDA labeling indicates that no dose adjustment is needed for patients with hepatic impairment
